Single gene biomarkers of CRC, such as TP53, APC, KRAS, and PIK3CA, have already been well-recognized of their high populational mutation occurrences, as well as their significant correlations with CRC prognosis (32–36). Here, TP53 is linked to colorectal carcinoma.